| Nov 1, 2025 |
Nov 4, 2025 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
51.3
|
-966
|
-0.28%
|
✗
|
$12.4K |
| Jun 2, 2025 |
Jun 4, 2025 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
17.5
|
-30,196
|
-15.20%
|
✓
|
$528.4K |
| Mar 3, 2025 |
Mar 4, 2025 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
46.3
|
-2,527
|
-1.73%
|
✗
|
$46.8K |
| Feb 27, 2025 |
Mar 3, 2025 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
40.0
|
-15,036
|
-9.33%
|
✗
|
$296.3K |
| Feb 27, 2025 |
Mar 3, 2025 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
20.0
|
-15,036
|
-9.33%
|
✗
|
$296.3K |
| Nov 1, 2024 |
Nov 4, 2024 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
52.5
|
-598
|
-0.37%
|
✗
|
$9.5K |
| Mar 1, 2024 |
Mar 5, 2024 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
46.3
|
-2,519
|
-1.55%
|
✗
|
$40.4K |
| Feb 27, 2024 |
Feb 29, 2024 |
NovoCure Ltd
|
EVP, Pres., Novocure Oncology |
Sell |
91.3
|
+100,171
|
160.41%
|
✗
|
$33.5K |
| Mar 3, 2023 |
Mar 7, 2023 |
NovoCure Ltd
|
President |
Sell |
10.0
|
-13,609
|
-20.04%
|
✓
|
$1M |
| Mar 2, 2023 |
Mar 6, 2023 |
NovoCure Ltd
|
President |
Sell |
95.0
|
+8,905
|
15.10%
|
✓
|
$223.4K |
| Mar 2, 2023 |
Mar 3, 2023 |
NovoCure Ltd
|
President |
Sell |
30.0
|
-4,107
|
-6.51%
|
✓
|
$309.6K |
| Feb 28, 2023 |
Mar 2, 2023 |
NovoCure Ltd
|
President |
Sell |
95.0
|
+16,937
|
36.69%
|
✗
|
$128.6K |
| Jan 5, 2023 |
Jan 9, 2023 |
NovoCure Ltd
|
President |
Sell |
23.8
|
-39,507
|
-8.60%
|
✓
|
$4.4M |
| Oct 13, 2022 |
Oct 17, 2022 |
NovoCure Ltd
|
President |
Sell |
20.0
|
-6,754
|
-13.41%
|
✗
|
$513.4K |
| Oct 6, 2022 |
Oct 7, 2022 |
NovoCure Ltd
|
President |
Sell |
20.0
|
-6,754
|
-11.82%
|
✗
|
$569.8K |
| Sep 29, 2022 |
Sep 30, 2022 |
NovoCure Ltd
|
President |
Sell |
20.0
|
-6,754
|
-10.57%
|
✗
|
$522.4K |
| Sep 22, 2022 |
Sep 26, 2022 |
NovoCure Ltd
|
President |
Sell |
20.0
|
-6,754
|
-9.56%
|
✗
|
$520.1K |
| Sep 15, 2022 |
Sep 19, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
17.5
|
-12,271
|
-14.80%
|
✗
|
$1.1M |
| Sep 8, 2022 |
Sep 13, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
20.0
|
-6,754
|
-8.03%
|
✗
|
$550.3K |
| Sep 9, 2022 |
Sep 12, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
22.5
|
-1,863
|
-2.17%
|
✗
|
$163.9K |
| Sep 6, 2022 |
Sep 7, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
22.5
|
-1,384
|
-1.58%
|
✗
|
$108.7K |
| Sep 1, 2022 |
Sep 6, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
37.5
|
-14,796
|
-14.48%
|
✗
|
$1.1M |
| Aug 2, 2022 |
Aug 3, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
51.3
|
-414
|
-0.40%
|
✗
|
$28.8K |
| Mar 8, 2022 |
Mar 9, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
45.0
|
-744
|
-0.72%
|
✗
|
$52.2K |
| Mar 3, 2022 |
Mar 7, 2022 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
95.0
|
+15,886
|
18.23%
|
✗
|
$108.4K |
| Sep 2, 2021 |
Sep 7, 2021 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
45.0
|
-540
|
-0.62%
|
✗
|
$74.6K |
| Aug 2, 2021 |
Aug 4, 2021 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
42.5
|
-1,041
|
-1.15%
|
✗
|
$155.5K |
| Mar 8, 2021 |
Mar 10, 2021 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
45.0
|
-765
|
-0.84%
|
✗
|
$100.1K |
| Mar 4, 2021 |
Mar 8, 2021 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
45.0
|
-567
|
-0.62%
|
✗
|
$78K |
| Mar 2, 2021 |
Mar 4, 2021 |
NovoCure Ltd
|
Chief Development Officer |
Sell |
90.0
|
+8,279
|
9.96%
|
✗
|
$65.4K |